Pharmaceutical giant GSK announced yesterday (Tuesday, July 28) that its site in Stevenage will close in 2029, with a new research and development facility created at Cambridge Biomedical Campus. Around 2,000 staff work for GSK at their Stevenage facility and, according to The Times, job losses are expected as part of the “phased” move to Cambridge. GSK have had a site in Stevenage since 1995, and announced plans to expand their presence in the town in 2021. The council has encouraged investment in Stevenage from STEM businesses, and expected there to be 8,000 new bioscience and life sciences jobs in the town by 2040. Stevenage’s MP, Kevin Bonavia, said he will “join the council and other Stevenage partners in banging the drum for major new investment” at GSK’s site.